Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nautilus Biotechnology (NAUT) Retained Earnings (2020 - 2026)

Nautilus Biotechnology has reported Retained Earnings over the past 7 years, most recently at -$346.7 million for Q1 2026.

  • Quarterly results put Retained Earnings at -$346.7 million for Q1 2026, down 19.7% from a year ago — trailing twelve months through Mar 2026 was -$346.7 million (down 19.7% YoY), and the annual figure for FY2025 was $243000.0, up 326.32%.
  • Retained Earnings reached -$346.7 million in Q1 2026 per NAUT's latest filing, down from $243000.0 in the prior quarter.
  • Across five years, Retained Earnings topped out at $243000.0 in Q4 2025 and bottomed at -$346.7 million in Q1 2026.
  • Median Retained Earnings over the past 5 years was -$138.6 million (2022), compared with a mean of -$135.0 million.
  • The largest annual shift saw Retained Earnings crashed 1110820.0% in 2022 before it skyrocketed 326.32% in 2025.
  • Over 5 years, Retained Earnings stood at -$138.6 million in 2022, then tumbled by 45.95% to -$202.2 million in 2023, then surged by 100.03% to $57000.0 in 2024, then soared by 326.32% to $243000.0 in 2025, then tumbled by 142774.9% to -$346.7 million in 2026.
  • Business Quant data shows Retained Earnings for NAUT at -$346.7 million in Q1 2026, $243000.0 in Q4 2025, and $200000.0 in Q3 2025.